PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Dec-2022 Global Fluorescent in Situ Hybridization Probe Market Report to 2027: Featuring Thermo Fisher Scientific, Roche Holdings, PerkinElmer and Sysmex Among Others - ResearchAndMarkets.com Businesswire
09-Dec-2022 Global Anti TIGIT Antibody Report 2022: Featuring Agenus, AstraZeneca, Bristol Myers and Merck Among Others - ResearchAndMarkets.com Businesswire
09-Dec-2022 QDENGA®▼ (vaccin tétravalent contre la dengue [vivant, atténué]) de Takeda est autorisé dans l'Union européenne Businesswire
09-Dec-2022 $4.8 Billion Worldwide Oligonucleotide Synthesis Industry to 2027: Players Include Agilent Technologies, Biolegio, Eurofins Genomics and GenScript Among Others - ResearchAndMarkets.com Businesswire
09-Dec-2022 QDENGA®▼ (tetravalenter Dengue-Impfstoff [abgeschwächter Lebendimpfstoff]) von Takeda erhält EU-Marktzulassung Businesswire
09-Dec-2022 Surface Disinfectant Global Market Report 2022: Increasing Healthcare Expenditures and An Emphasis on Them in Emerging Nations Presents an Opportunity - ResearchAndMarkets.com Businesswire
09-Dec-2022 AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance Businesswire
09-Dec-2022 Ecolab Appoints Eric Green to Board of Directors Businesswire
09-Dec-2022 Labcorp Opens New Los Angeles Based Laboratory Businesswire
09-Dec-2022 FOXO LIFE™ to Begin Distribution Relationship with AmSuisse to Sell Life Insurance Designed to Keep You Alive™ Businesswire
09-Dec-2022 Exelixis Provides Update on Phase 3 CONTACT-01 Trial Evaluating Cabozantinib in Combination with Atezolizumab in Patients with Metastatic Non-Small Cell Lung Cancer Previously Treated with Immunotherapy and Chemotherapy Businesswire
09-Dec-2022 Ipsen communique le résultat de l’essai de Phase III CONTACT-01 évaluant cabozantinib associé avec atézolizumab chez les patients déjà traités par immunothérapie et chimiothérapie atteints d’un cancer du poumon non à petites cellules métastatique Businesswire
09-Dec-2022 Ipsen Provides Update On Phase III CONTACT-01 Trial Evaluating Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Non-small Cell Lung Cancer Previously Treated With Immunotherapy and Chemotherapy Businesswire
08-Dec-2022 QDENGA®▼ da Takeda (vacina tetravalente contra dengue [viva, atenuada]) aprovada para uso na União Europeia Businesswire
08-Dec-2022 Global Genomics Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts - ResearchAndMarkets.com Businesswire
08-Dec-2022 Healthcare Adhesive Tapes Global Market Report 2022: Featuring 3M, Cardinal Health, Nitto Denko, Johnson & Johnson, & Paul Hartmann - ResearchAndMarkets.com Businesswire
08-Dec-2022 Global Pharma, Biotech & Diagnostics Co-promotion and Co-marketing Partnering Terms and Agreements Analysis Report 2022 - ResearchAndMarkets.com Businesswire
08-Dec-2022 Global Coronavirus Partnering Deals Analysis Report 2022: Gain Access to Headline, Upfront, Milestone and Royalty Data - ResearchAndMarkets.com Businesswire
08-Dec-2022 Sonde Health Raises $19.25 Million Series B to Build the Next Generation of Voice-Based Health Monitoring Businesswire
08-Dec-2022 Medidata Receives Prestigious Innovation Award from Reagan-Udall Foundation for the FDA Businesswire